What 10 Analyst Ratings Have To Say About HCA Healthcare
Within the last quarter, HCA Healthcare (NYSE:HCA) has observed the following analyst ratings:
Raymond James Maintains Outperform on HCA Healthcare, Raises Price Target to $300
Raymond James analyst John Ransom maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $290 to $300.
Where HCA Healthcare Stands With Analysts
Over the past 3 months, 9 analysts have published their opinion on HCA Healthcare (NYSE:HCA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Stephens & Co. Maintains Overweight on HCA Healthcare, Raises Price Target to $283
Stephens & Co. analyst Scott Fidel maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $275 to $283.
Citigroup Maintains Neutral on HCA Healthcare, Raises Price Target to $274
Citigroup maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $268 to $274.
RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $291
RBC Capital analyst Frank Morgan maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $273 to $291.
Credit Suisse Maintains Outperform on HCA Healthcare, Raises Price Target to $298
Credit Suisse analyst Jonathan Yong maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $267 to $298.
Oppenheimer Maintains Outperform on HCA Healthcare, Raises Price Target to $290
Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $275 to $290.
HCA Healthcare Beats Consensus In Q3, Raises FY21 Outlook
HCA Healthcare Inc’s (NYSE:HCA) third-quarter FY21 revenues increased to $15.3 billion, up 14.8% year-on-year, beating the consensus of $14.4 billion. EPS of…
HCA Healthcare Q3 Adj. EPS $4.57 Beats $4.00 Estimate, Sales $15.28B Beat $14.43B Estimate
HCA Healthcare (NYSE:HCA) reported quarterly earnings of $4.57 per share which beat the analyst consensus estimate of $4.00 by 14.25 percent. This is a 138.02 percent increase over earnings of $1.92 per share from the